2-DG: Granules India Gets Licence from DRDO to Manufacture and Market Covid Drug

Developed by DRDO, 2-DG has been granted permission by DCGI for emergency use as adjunct therapy in moderate to severe COVID-19 patients.

Similar Articles

Most Popular